Development and preliminary testing of an inactivated equine adenovirus vaccine.
D000256:Adenoviridae / Q000187:drug effects / Q000276:immunology* / Q000528:radiation effects; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D006734:Horse Diseases / Q000276:immunology / Q000517:prevention & control; D006736:Horses / Q000276:immunology*; D051379:Mice; D011420:Propiolactone / Q000494:pharmacology; D011817:Rabbits; D014613:Vaccines, Attenuated / Q000008:administration & dosage*; D014765:Viral Vaccines / Q000008:administration & dosage
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D011420:Propiolactone